Research shows that use of immunosuppressive medication and subsequent stem cell transplant can cure multiple sclerosis. Clinical trials conducted five years ago revealed that more than half of the patients treated with high-dose immunosuppressive drugs and hematopoietic cell transplantation (HDIT/HCT) did not develop multiple sclerosis or brain damage. This trial was funded and supported by National Institute of Allergy and Infectious Diseases (NIAID) and NIH. This five-year study produced remarkable results that were published in the American Academy of Neurology Journal.
According to NIAID’s director Anthony Fauci, short-term therapy with HDIT/HCT is potent in the treatment of multiple sclerosis (MS). MS symptoms include fatigue, speech difficulties, chronic pain, and weakness. These findings are important and will aid in improving the standard of care for patients with this condition. About 24 volunteers with remitting MS enrolled into the study, and they were put on HDIT/HCT therapy, which served to suppress the disease. The lead scientist on this study was Dr. Richard Nash from the Presbyterian St. Luke’s Hospital and the Colorado Blood Cancer Institute.
Dr. Shiva’s educational background and work history
Dr. Shiva Gopal Vasishta is a psychiatrist based in Voorhees, New Jersey. Dr. Shiva is bilingual and speaks both Spanish and English. He has 40 years of work experience in the field of medicine. Dr. Shiva Vasishta studied medicine in the Government Medical College Nagpur in 1979. He undertook his residency at Boston City Hospital and the Tufts Medical Centre. Dr. Shiva is also a specialist in neurology.
Dr.Shiva Vasishta practices at Neurodiagnostic Associates, a facility that works in collaboration with Kennedy Health System Cherry Hill Campus. He is open-minded and accepts patients with insurance covers from the Horizon Blue Cross Blue Shield and the Aetna Medicare. Dr. Shiva is a member of the Eastern Neurodiagnostic Association. He also managed Medicare Advantage programs.